Skip to content

Cancers & treatments

News & evidence

Living with cancer

Learn & contribute

Loading

A public, cited, editable map of oncology: technologies, targets, products, companies, institutions, pathways, trials, pairings, roadmaps, and ideas. One page per object, with a plain-language TL;DR on every page.

Work in progress. Every fact on this site is being built and checked in the open and may be incomplete, out of date, or wrong. You must do your own research and verify anything here at its primary source before relying on it. Nothing on this site is medical advice; decisions belong with you and your clinicians.

OnCo is an information resource, not medical advice. Nothing here replaces a conversation with a qualified clinician. Never delay care because of something you read here; in an emergency, call your local emergency services. Terms of use

Browse by cancer
Tags
Search
Connections
For me
Navigator
Biomarker matrix
Calculators
Interactions
Decision aids
Checkpoint side effects
Tumour board
Compare
Counts by category
Rankings
Timeline
Year by year
Query builder
Graph explorer
Saved
Body map

Cancers & treatments

News & evidence

Institutions & people

Institutions
Universities
Trial leadership
People
Heroes and heroines
Companies
Startups
Requests for startups
Investors
Company scorecards
Trial sponsors
Manufacturing map
Countries
United States deep dive
India deep dive
China deep dive
Germany deep dive
Israel deep dive
United Kingdom deep dive
Cases by country
Funding flows

Living with cancer

For me
The first 60 days
Appointment prep pack
Side effects
Symptom to test
Report reader
Survivorship planner
Second opinion
Financial help
Free in oncology
Paying for care in the US
NHS coverage
Paying for care in India
Coverage rankings
Cutting cancer care costs
Diet, exercise and lifestyle
Supportive care
Recovery and rejuvenation
Complementary and supportive approaches
Hair loss and regrowth
What comes back after treatment
Heroes and heroines

Learn & contribute

Reading paths
About & methodology
Roadmap
Gaps to fill
Coverage of the field
Review queue
Reviewer roster
Contributors
Idea votes
Teaching packs
Weekly issue
Suggest an edit
Answer quality
Data dictionary
Build on OnCo
Open API
Open data
Open tools
Open source in oncology
The software of oncology
GitHub

© 2026 OnCo. Code MIT. The data are free for individual and educational use with the attribution “Data from OnCo (onco.cc)”, under CC BY-NC 4.0. Commercial use must contact us to pay for the data. Commercial licences. Made with heart and soul by Jude Gomila .

About and methodology Corrections Open API Tags Terms of use Privacy policy GitHub

Loading

Home
Cancers
Craniopharyngioma
Data

Cancers·Craniopharyngioma

DataCraniopharyngioma

Back to the Craniopharyngioma hub →36 connected records

Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.

Overview Types and stages Symptoms and diagnosis Treatment Trials and papers Biology and targets Countries and centres Decisions and support Pipeline and open problems Data

Data

Related pages

36

Direct links plus the targets, companies, and technologies of this cancer's products.

Similar pages

Cancer
Ependymoma
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, St. Jude Children's Research Hospital and the tags paediatric, cns.
Cancer
Atypical teratoid/rhabdoid tumour (ATRT)
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, Central nervous system germ cell tumours (germinoma and non-germinomatous) and the tags paediatric, cns.
Cancer
Diffuse midline glioma, H3 K27-altered (including DIPG)
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, Paediatric low-grade glioma and the tags paediatric, cns.
Trial
TADPOLE (CDRB436G2201)
Shares Dabrafenib + trametinib, Paediatric low-grade glioma, BRAF, RAS / RAF / MEK / ERK (MAPK) and the tags paediatric, cns.
Cancer
Medulloblastoma
Shares Brain tumor pathology, CNS oncology, Journal of neuro-oncology, Central nervous system germ cell tumours (germinoma and non-germinomatous) and the tags paediatric, cns.
Trial
FIREFLY-1
Shares Paediatric low-grade glioma, BRAF, RAS / RAF / MEK / ERK (MAPK) and the tags paediatric, cns.
Trial
ACTION
Shares Rare and paediatric cancers without markets and the tags paediatric, cns.
Cancer
WNT-activated medulloblastoma
Shares St. Jude Children's Research Hospital, Wnt / β-catenin, Children's Oncology Group (COG), Survivorship care and late-effects surveillance and the tags paediatric, cns.

technologies

Cytokines & engineered cytokines Cytotoxic chemotherapy Electrochemotherapy GLP-1 receptor agonists and obesity-related cancer risk IMRT / IGRT (modern external beam)MRI Proton therapy Small-molecule kinase inhibitors Survivorship care and late-effects surveillance

targets

drugs

ApprovedGlycopeptide antibiotic (DNA-cleaving)

Bleomycin · Blenoxane

ApprovedSmall-molecule kinase inhibitor (MEK1/2)

Cobimetinib · Cotellic

ApprovedSmall-molecule kinase inhibitors (BRAF + MEK)

Dabrafenib + trametinib · Tafinlar + Mekinist

HistoricRecombinant type I interferon (cytokine)

Interferon alfa-2a/2b · Roferon-A / Intron A / Sylatron

ApprovedSubcutaneous melanocortin-4 receptor agonist

Setmelanotide · Imcivree

ApprovedSmall-molecule kinase inhibitor (BRAF V600)

Vemurafenib · Zelboraf

companies

Alliance for Clinical Trials in Oncology Children's Oncology Group (COG)Merck & Co. (MSD)Novartis Rhythm Pharmaceuticals Roche / Genentech

institutions

St. Jude Children's Research Hospital

pathways

Inflammation & NF-κB RAS / RAF / MEK / ERK (MAPK)Wnt / β-catenin

terms

Late effects and survivorship toxicity

trials

FOG-001 in Locally Advanced or Metastatic Solid Tumors TRANSCEND

bottlenecks

Rare and paediatric cancers without markets Survivorship and late effects are neglected

key papers

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas Setmelanotide for the treatment of acquired hypothalamic obesity (TRANSCEND)

journals

Brain tumor pathology CNS oncology Journal of neuro-oncology

Machine-readable versions

The same record for scripts and assistants; checked 2026-09-10. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.

JSON with neighbours Markdown context RDF Turtle Sections with routes and counts API root

ProvenanceLast edited 2026-09-27 · Jude Gomila · Say what the cancer does, not how to feel about it · diff · file

Wikipedia

Craniopharyngioma

Sources & links

NCI PDQ: childhood craniopharyngioma
Alliance A071601: BRAF/MEK inhibition in papillary craniopharyngioma (Lancet Oncology 2024)
Brastianos 2014: exome sequencing of craniopharyngioma (Nature Genetics)

Data

JSON ·

Follow this page

Wrong or missing?

Propose a change with a source. Organisations can update their own records. Every suggestion is reviewed, safety-checked and validated before it goes live; nothing is edited directly.

Suggest an editDiscuss start a thread

Out of date?
How review works

Not yet reviewedNeeds expert (clinical) and patient advocate review. Review this page or see the review queue and roster.

Model panel commentary is coming to this page: machine commentary, not clinical review.

Machine-readable versions of Craniopharyngioma

JSON record with neighbours
Markdown context for language models
RDF Turtle for this record (its triples, relations and owl:sameAs; the IRI of this record is https://onco.cc/cancers/craniopharyngioma/)
Section plan: the ten sections of this record with routes, anchors and counts
All cancers as JSON
RDF N-Triples for the whole corpus
Search index: id, kind, name, TL;DR and route for every record
OpenAPI 3.1 description
API root and meta.json
llms.txt

MCP server: npx -y onco-mcp, tools search, get_entity, list_kind, ask, context, compare. This record is get_entity or context with id craniopharyngioma.

WebMCP tools registered on this page: onco_search, onco_get_entity.